C-RVV

C:RVV - Revive Therapeutics Ltd. - http://www.revivethera.com

22:06:32 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RVV - C	880.8	0.025	·	0.03	267.5	0.025			219.6	6	19	0.0275 0.03 0.025	0.095 0.02	13:52:48	10:17	15 min RT 2¢
CSE - C	880.8	0.025	·	0.03	267.5	0.025			192.1	5	11	0.03 0.03 0.025	0.095 0.02	10:47:22		15 min
NEO ATS - U						0.025			5.0	0	1	0.025 0.025 0.025		13:52:48		15 min
Omega - O						0.03	+0.005	20.0	1.0		1	0.03 0.03 0.03		12:20:28		15 min
CX2 - H						0.03	+0.005	20.0	1.0		1	0.03 0.03 0.03		13:48:59		15 min
CXD - D						0.0275	+0.0025	10.0	20.1	0	3	0.0275 0.0275 0.0275		10:02:07		15 min
TriAct - M						0.025			0.5		2			Sep 08-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 19

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
13:52:48	U	0.025		5,000	2 RBC	2 RBC	K
13:48:59	H	0.03	0.005	1,000	80 National Bank	1 Anonymous	K
13:48:59	M	0.03	0.005	161	80 National Bank	80 National Bank	E
12:20:28	O	0.03	0.005	1,000	1 Anonymous	1 Anonymous	K
12:20:28	M	0.03	0.005	289	7 TD Sec	7 TD Sec	E
10:47:22	C	0.025		7,000	7 TD Sec	7 TD Sec	K
10:02:07	C	0.03	0.005	29,000	7 TD Sec	19 Desjardins	K
10:02:07	C	0.03	0.005	20,000	7 TD Sec	19 Desjardins	K
10:02:07	C	0.03	0.005	1,000	7 TD Sec	80 National Bank	K
10:02:07	C	0.03	0.005	5,000	7 TD Sec	124 Questrade	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-04-23 10:17	C:RVV	0.025	News Release200	Revive receives Bucillamine FDA Type C meeting approval
2024-04-18 10:56	C:RVV	0.025	News Release200	Revive gets FDA acceptance for meeting request
2024-04-02 11:21	C:RVV	0.03	News Release200	Revive clinical study enrolls nearly 50% of sample
2024-03-27 13:25	C:RVV		News Release200	Revive submits meeting request to U.S. FDA